In our ongoing effort to bring accessible cancer diagnostics to the regions that need them most, we are proud to announce the official launch of Digistain’s first international lab in South Africa. In partnership with OriGenes and UVU Africa, this lab further enhances the speed and efficiency of our already rapid assay.
With a dedicated and expert team on the ground, patients across Africa will now have access to timely, accurate risk stratification for breast cancer, helping to improve treatment planning and outcomes. This launch marks an important step forward in our mission to make equitable cancer diagnostics a reality for underserved communities.
